GNPX Latest Press Releases

-- October 28, 2026 --

Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting PRNewswire 7:01 AM

-- October 21, 2026 --

Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA, in Maintaining Cellular Function During Brain Aging PRNewswire 7:01 AM

-- September 8, 2026 --

Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 8:00 AM

-- August 18, 2026 --

Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy PRNewswire 7:00 AM

-- August 3, 2026 --

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies PRNewswire 7:00 AM

-- June 22, 2026 --

Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer PRNewswire 9:00 AM

-- June 17, 2026 --

Genprex to Participate at BIO International Convention 2026 PRNewswire 9:01 AM

Market Data Delayed 15 Minutes